Elixir Pharmaceuticals
Latest round
- Series E
Last raised
- May 2009
Total raised
- $80M
Investors
- 8
About Elixir Pharmaceuticals
Elixir Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the discovery, development, and commercialization of novel pharmaceuticals for the treatment of metabolic diseases.
Who invested in Elixir Pharmaceuticals
8 investors across 4 rounds
See all investors in Elixir Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Elixir Pharmaceuticals
Who invested in Elixir Pharmaceuticals?
Elixir Pharmaceuticals has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Elixir Pharmaceuticals raised?
Elixir Pharmaceuticals has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Elixir Pharmaceuticals last raise money?
Elixir Pharmaceuticals's most recent round on record is a Series E, in May 2009.
What does Elixir Pharmaceuticals do?
Elixir Pharmaceuticals is a pharmaceuticals company.
Where is Elixir Pharmaceuticals headquartered?
Elixir Pharmaceuticals is headquartered in Cambridge, US.
Which VCs invest in companies like Elixir Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Elixir Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series E
Raising like Elixir Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.